⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ENTX News
Entera Bio Ltd. Ordinary Shares
Correction: Entera to Participate in Upcoming Fall Investor Conferences
globenewswire.com
ENTX
Entera to Participate in Upcoming Fall Investor Conferences
globenewswire.com
ENTX
Form 8-K
sec.gov
ENTX
Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation
globenewswire.com
ENTX
Form 8-K
sec.gov
ENTX
Entera Announces Second Quarter 2026 Financial Results and Business Updates
globenewswire.com
ENTX
Entera Bio Phase 2 Data Supporting EB613’s (Oral PTH(1-34)) Anabolic Effect on Postmenopausal Women with Osteoporosis at High Risk for Fracture Selected for Plenary Poster Session Presentation at the ASBMR 2026 Annual Meeting
globenewswire.com
ENTX
Entera Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
globenewswire.com
ENTX
Greenberg Traurig Advises Entera Bio in Record $275M Israeli Biotech PIPE
prnewswire.com
ENTX
Form 8-K
sec.gov
ENTXW
ENTX